Cannabis Science Inc. Cannabis Science Inc.
Cannabis Science Inc. Cannabis Science Inc.
  • Home
  • About Us
    • Corporate Overview
    • Mission Statement
    • Cannabis Science Team
    • Careers & Corporate Culture
  • iCannabinoid
    • Join Now!
  • R&D
    • The Science of Cannabinoids
    • CBIS Cannabinoid Research
    • Critical Ailments
  • COLLABORATIONS & PROJECTS
    • CBIS Medical Consortium
    • Global Economic Development
    • Pan African A & C University
    •     African Economic Initiative
    • American States University
    •     North American Economic Initiative
    • Dana-Farber
    • CFA
    • Stellenbosch University
    • CBIS Bottle It
  • Products & Pharmacies
    • Products
    • Order Online
    • Pharmacies
  • Investors
    • CBIS Current Share Structure
    • SEC Filings
  • Media
    • CBIS News Releases
    • CBIS In The News
    • CBIS Events
  • Contact

latest Articles

  • Cannabis Science Issues 2019 Guidance Report; Under SEC Sanctions the Company Goes Private as It Enters Into Step (2) of Its Growth Transition, Enabling Full Transparency and Revenue Growth
  • Cannabis Science Enters Transition Stage as Trading of the Company’s Shares is Halted; The Company Will Continue to Implement Its Growth Strategy and Resolve All Outstanding Fully Reporting Requirements
  • Cannabis Science Partners With CDN Firm NHS Industries to Launch the CBIS CDN Economic Development Plan; CBIS to Use Its Relations With the Harvard International Phytomedicines and Medical Cannabis Institute and Other Leading Institutions
  • Cannabis Science Prepares Announcements for Revenues and Corporate Growth; Finalizing New Asset Partnerships and Acquisitions Targeting Positive Cash Flow in Key Markets Globally
  • Cannabis Science Successfully Completes European Headquarters and Operations Move to The Netherlands and Completes Shut Down of All Cannabis Science Europe GmbH Germany Operations

  1. Home

Total: 448 results found.

Page 3 of 23

Cannabis Science and FSO NAC Sign for New 100-Acre Property in Minden, Nevada as the Industrial Hemp Research Projects in Nevada Continue to Flourish for the Group

Created on 2018-08-14 15:53:23

Cannabis Science Research Group FSO NAC / HRM Farms Receives Approvals From the Nevada Department of Agriculture for its Newest 40-Acre Industrial Hemp Research Project in Nevada

Created on 2018-08-14 15:34:32

Cannabis Science Celebrates the Lives and Mourns the Loss of Dr. Allen Herman and The Honorable Ronald V. Dellums

Created on 2018-08-11 16:35:14

Cannabis Science, Harvard Medical School's Global Health Catalyst, Elpasso Farms (South Africa), and American States University Partner to Strengthen Africa's Economic and Healthcare Infrastructure

Created on 2018-08-11 04:19:32

Global Health Catalyst Summit 2018.

Created on 2018-07-05 19:46:25

CBIS Black Tie Gala 2018.

Created on 2018-07-05 16:51:24

CBIS BOTTLE IT

Created on 2018-07-03 23:49:00

CBIS Team

Created on 2018-06-28 02:51:53

Ronald H. Brown African Affairs Series.

Created on 2018-06-25 23:26:45

CBIS Releases Corporate Operational Guidance for 2013 as the Company Reorganizes to Better Meet the Growing Global Crisis Associated with Anti-Retroviral Drug Resistance Among People with AIDS, as well as the Increasing Need for Patient Friendly Skin Canc

Created on 2018-06-14 19:20:10

Cannabis Science Appoints Richard Ogden, PhD, Former Director of Scientific Affairs, HIV, Pfizer, as Chief Scientific Officer

Created on 2018-06-14 19:19:06

Cannabis Science, Inc. Appoints Michael McGrath, MD, PhD, Professor, Departments of Laboratory Medicine, Pathology, and Medicine, UCSF, and Co-Founder of Biotechs Pathologica LLC and Neuraltus Pharmaceuticals, to the Company's Scientific Advisory Board

Created on 2018-06-14 19:15:57

Cannabis Science (CBIS) Announces Plans for Observational Research Study in 2014

Created on 2018-06-14 17:57:41

Greta Gaines Former Member of the National Board of the National Organization to Reform Marijuana Law (NORML) Joins Cannabis Science (CBIS) Team to Enhance Company's Business Development Activities

Created on 2018-06-14 17:56:47

Cannabis Science (CBIS) Government Affairs Representative Lobbys' with the U.S. House of Representatives' Cannabis Caucus for President Obama to Join Congressional Cannabis Caucus in Ending Federal Restrictions on Cannabinoid Research

Created on 2018-06-14 17:55:59

CBIS Provides Growth Guidance on its Medicine Dispensing Systems (MDS) Exclusive & Non-Exclusive Agreements

Created on 2018-06-14 17:54:58

Cannabis Science (CBIS) Applauds U.S. Congress on Moving to Legalize Hemp Cultivation and Research; Calls Today for Final Senate Passage of Farm Bill and President's Signature into Law

Created on 2018-06-14 17:54:23

Cannabis Science (CBIS) Collaborates with Patients Out of Time, Inc., a Global Patient Advocacy Organization Dedicated to Educating Health Professionals and the Public about Therapeutic Cannabis

Created on 2018-06-14 17:53:11

Cannabis Science (CBIS) Signs Partnership Agreement with Michigan Green Technologies, LLC to Focus on Reform and Proper Implementation of Cannabis and Commercial Hemp Programs for the State of Michigan

Created on 2018-06-14 17:51:58

Cannabis Science Negotiates $1 Million Financing for Progression of Products and Start of Observational Trials

Created on 2018-06-14 17:51:03

  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next
  • End
REACH US.

2019 US Federal Contractor

DUNS number: 830406356
CAGE code: 5FZM9

NAICS Codes selected:

541711 - Research and Development in Biotechnology

621511 - Medical Laboratories

624230 - Emergency And Other Relief Services

Contact.

Cannabis Science Inc.

Mr. Raymond C. Dabney
President & CEO

raymond.dabney@cannabisscience.com



 
 
Copyright © 2019 Cannabis Science Inc. All Rights Reserved.